Immortal time bias in the study of effectiveness of interferon-β in multiple sclerosis

被引：19
|
作者：
Renoux, Christel [1 ]
Suissa, Samy
机构：
[1] McGill Univ, Ctr Hlth, Div Clin Epidemiol, Dept Epidemiol & Biostat, Montreal, PQ, Canada
来源：
ANNALS OF NEUROLOGY | 2008年 / 64卷 / 01期
关键词：
D O I：
10.1002/ana.21352
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：109 / 110
页数：2
相关论文
共 50 条
  • [21] Immortal time bias in cohort studies of inhaled corticosteroid effectiveness
    Suissa, S
    EUROPEAN RESPIRATORY JOURNAL, 2003, 22 : 24S - 26S
  • [22] | Immortal time bias
    Ranstam, Jonas
    Cook, Jonathan A.
    BRITISH JOURNAL OF SURGERY, 2022, 109 (07) : 642 - 642
  • [23] Immortal time bias
    Obel, Niels
    AIDS, 2015, 29 (07) : 859 - 860
  • [24] Binding antibodies to interferon-β in Iranian multiple sclerosis patients treated with different interferon-β preparations
    Vaezeafshar, R
    Hooshmand, E
    Jangouk, P
    Amirzargar, A
    Nikbin, B
    Lotfi, J
    Soltanzodeh, S
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S253 - S253
  • [25] Myxovirus Resistance Protein A in Interferon-β Therapy in Patients with Multiple Sclerosis and Treatment Effectiveness Monitoring Algorithm
    Libertinova, J.
    Meluzinova, E.
    Havrdova, E.
    Horakova, D.
    Kovarova, I.
    Hyncicova, E.
    Liskova, R.
    Houzvickova, E.
    Mat'oska, V.
    Zajac, M.
    Tomek, A.
    Bojar, M.
    Marusic, P.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2016, 79 (05) : 547 - 551
  • [26] Long-term interferon-β treatment for multiple sclerosis
    R. M. Ruggieri
    N. Settipani
    L. Viviano
    M. Attanasio
    L. Giglia
    P. Almasio
    V. La Bella
    F. Piccoli
    Neurological Sciences, 2003, 24 : 361 - 364
  • [27] Treatment of Multiple Sclerosis with the Interferon-βsComparative Risks and Benefits
    Robert McCulloch Herndon
    BioDrugs, 1998, 10 : 463 - 470
  • [28] Clinical testing for neutralizing antibodies to interferon-β in multiple sclerosis
    Creeke, Paul I.
    Farrell, Rachel A.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2013, 6 (01) : 3 - 17
  • [29] Interferon-β in the treatment of relapsing-remitting multiple sclerosis
    Revel, M
    PHARMACOLOGY & THERAPEUTICS, 2003, 100 (01) : 49 - 62
  • [30] Long-term interferon-β treatment for multiple sclerosis
    Ruggieri, RM
    Settipani, N
    Viviano, L
    Attanasio, M
    Giglia, L
    Almasio, P
    La Bella, V
    Piccoli, F
    NEUROLOGICAL SCIENCES, 2003, 24 (05) : 361 - 364
12345